I-Mab
NASDAQ:IMAB

Watchlist Manager

I-Mab

NASDAQ:IMAB

Watchlist

Dividends

Price: 0.9397 USD -2.01% Market Closed

Market Cap: 76m USD

Have any thoughts about
I-Mab?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 0.9397 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

IMAB Alert

I-Mab

0.9397

-0.0193 (-2.01%)

52 Week Range	0.9397 2.37
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

I-Mab

What unique competitive advantages
does I-Mab hold over its rivals?

What risks and challenges
does I-Mab face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of I-Mab.

What unique competitive advantages
does I-Mab hold over its rivals?

What risks and challenges
does I-Mab face in the near future?

Summarize the latest earnings call
of I-Mab.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for I-Mab.

Provide P/S
for I-Mab.

Provide P/E
for I-Mab.

Provide P/OCF
for I-Mab.

Provide P/FCFE
for I-Mab.

Provide P/B
for I-Mab.

Provide EV/S
for I-Mab.

Provide EV/GP
for I-Mab.

Provide EV/EBITDA
for I-Mab.

Provide EV/EBIT
for I-Mab.

Provide EV/OCF
for I-Mab.

Provide EV/FCFF
for I-Mab.

Provide EV/IC
for I-Mab.

Show me price targets
for I-Mab made by professional analysts.

What are the Revenue projections
for I-Mab?

How accurate were the past Revenue estimates
for I-Mab?

What are the Net Income projections
for I-Mab?

How accurate were the past Net Income estimates
for I-Mab?

What are the EPS projections
for I-Mab?

How accurate were the past EPS estimates
for I-Mab?

What are the EBIT projections
for I-Mab?

How accurate were the past EBIT estimates
for I-Mab?

Compare the revenue forecasts
for I-Mab with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of I-Mab and its key competitors using the latest financial data.

Compare historical revenue growth rates
of I-Mab against its competitors.

Analyze the profit margins
(gross, operating, and net) of I-Mab compared to its peers.

Compare the P/E ratios
of I-Mab against its peers.

Discuss the investment returns and shareholder value creation
comparing I-Mab with its peers.

Analyze the financial leverage
of I-Mab compared to its main competitors.

Show all profitability ratios
for I-Mab.

Provide ROE
for I-Mab.

Provide ROA
for I-Mab.

Provide ROIC
for I-Mab.

Provide ROCE
for I-Mab.

Provide Gross Margin
for I-Mab.

Provide Operating Margin
for I-Mab.

Provide Net Margin
for I-Mab.

Provide FCF Margin
for I-Mab.

Show all solvency ratios
for I-Mab.

Provide D/E Ratio
for I-Mab.

Provide D/A Ratio
for I-Mab.

Provide Interest Coverage Ratio
for I-Mab.

Provide Altman Z-Score Ratio
for I-Mab.

Provide Quick Ratio
for I-Mab.

Provide Current Ratio
for I-Mab.

Provide Cash Ratio
for I-Mab.

What is the historical Revenue growth
over the last 5 years for I-Mab?

What is the historical Net Income growth
over the last 5 years for I-Mab?

What is the current Free Cash Flow
of I-Mab?

Discuss the annual earnings per share (EPS)
trend over the past five years for I-Mab.

IMAB

Balance Sheet

Accrued Liabilities

I-Mab
Accrued Liabilities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

I-Mab
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

	Accrued Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
I-Mab NASDAQ:IMAB	Accrued Liabilities ¥21.9m	CAGR 3-Years -66%	CAGR 5-Years -20%	CAGR 10-Years N/A
Beigene Ltd HKEX:6160	Accrued Liabilities ¥2.6B	CAGR 3-Years 49%	CAGR 5-Years 55%	CAGR 10-Years N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd SSE:603392	Accrued Liabilities ¥268.5m	CAGR 3-Years 37%	CAGR 5-Years 39%	CAGR 10-Years N/A
Shanghai RAAS Blood Products Co Ltd SZSE:002252	Accrued Liabilities ¥164.1m	CAGR 3-Years 50%	CAGR 5-Years 30%	CAGR 10-Years 19%
Chongqing Zhifei Biological Products Co Ltd SZSE:300122	Accrued Liabilities ¥325.2m	CAGR 3-Years -23%	CAGR 5-Years 21%	CAGR 10-Years 45%
Imeik Technology Development Co Ltd SZSE:300896	Accrued Liabilities ¥116.1m	CAGR 3-Years 52%	CAGR 5-Years 49%	CAGR 10-Years N/A

No Stocks Found

I-Mab
Glance View

Market Cap

76m USD

Industry

Biotechnology

I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-01-17.

Open IMAB Analysis

IMAB Intrinsic Value

0.7454 USD

Overvaluation 21%

Intrinsic Value

Price

What is Intrinsic Value?

What is I-Mab's Accrued Liabilities?

Accrued Liabilities
21.9m CNY

Based on the financial report for Dec 31, 2023, I-Mab's Accrued Liabilities amounts to 21.9m CNY.

What is I-Mab's Accrued Liabilities growth rate?

Accrued Liabilities CAGR 5Y
-20%

Over the last year, the Accrued Liabilities growth was -97%. The average annual Accrued Liabilities growth rates for I-Mab have been -66% over the past three years , -20% over the past five years .

I-Mab
NASDAQ:IMAB

I-Mab
Accrued Liabilities

I-Mab
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

I-Mab
Glance View

See Also

What is I-Mab's Accrued Liabilities?

Accrued Liabilities
21.9m CNY

What is I-Mab's Accrued Liabilities growth rate?

Accrued Liabilities CAGR 5Y
-20%

Company

Help

Tools

Stocks

I-Mab NASDAQ:IMAB

I-Mab Accrued Liabilities

I-Mab Accrued Liabilities Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

I-Mab Glance View

See Also

What is I-Mab's Accrued Liabilities? Accrued Liabilities 21.9m CNY

What is I-Mab's Accrued Liabilities growth rate? Accrued Liabilities CAGR 5Y -20%

Company

Help

Tools

Stocks

I-Mab
NASDAQ:IMAB

I-Mab
Accrued Liabilities

I-Mab
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

I-Mab
Glance View

What is I-Mab's Accrued Liabilities?

Accrued Liabilities
21.9m CNY

What is I-Mab's Accrued Liabilities growth rate?

Accrued Liabilities CAGR 5Y
-20%